Introducing: The First m6A-eCLIP Kit

Directly identify m6A modification sites using Eclipse’s enhanced CLIP technology

JOIN THE RNA REVOLUTION!

Savvy researchers today are advancing their research by understanding the effects of RNA modifications in their studies.

The m6A-eCLIP Kit is a targeted RNA modification kit that has applications in many fields of research. The kit allows researchers studying cancer, autoimmune diseases, viral infections and neurological disorders among others to globally map m6A RNA modification states

Advantages

High Throughput and Robust Workflow
A simplified version of the Nature Methods-published eCLIP protocol enables profiling m6A marks with 40-fold less mRNA input than other approaches

Highly Reproducible with accurate data
Significant improvements in signal/noise reproducibly identifies m6A modified RNAs

Unbiased with high specificity
m6A eCLIP captures the DRACH motif and recapitulates other m6A profiling methods

Workflow 

Starting with purified RNA, the m6A eCLIP Kit combines the use of an m6A antibody with the eCLIP technology, based on Van Nostrand et al. (Nature Methods, 2016) that allows users to accurately and robustly identify and map RBP binding sites on target RNAs.

The streamlined 4-5 day protocol is easy to process, produces high quality libraries, and can be broken down into multiple start and stop steps. The kit enables the user to do mRNA isolation, m6A IP and library prep on up to 8 high quality samples.

Related articles

Uncategorized

10
26
21

Eclipse Bio’s RBP-eCLIP™ kit has enabled the discovery of Ago2 particles forming from Gαq activation

Eclipse Bio’s RBP-eCLIP™ kit was cited in a recent publication, enabling the discovery of Ago2 particles forming from Gαq activation. Explore Advanced RNA Genomics Solutions. Find the publication here.

read more

Uncategorized

10
21
21

Eclipse Bio’s m6A-eCLIP™ service has enabled the discovery of Mettl3 as a p53-interacting protein.

Eclipse Bio’s m6A-eCLIP™ service was cited in a recent publication, enabling the discovery of Mettl3 as a p53-interacting protein. Explore Smarter RNA Genomics Solutions. Find the publication here.

read more

Uncategorized

10
15
21

Eclipse Bio’s miR-eCLIP™ service has enabled the discovery of Tobramycin as a suppressing factor in lung inflammation

Eclipse Bio’s miR-eCLIP™ service was cited in a recent publication, enabling the discovery of Tobramycin as a suppressing factor in lung inflammation, and as a gene silencing mechanism reducing IL-8 secretion in CF-HBECSs. Find the publication here.

read more

Uncategorized

10
15
21

Win a Free Kit! Enter our Grant Proposal Competition

Don’t miss out on this opportunity to win one of our kits! Eclipse Bio will be conducting a grant proposal competition! To enter, follow the directions above, and fill out a quick questionnaire to describe how you would take advantage of our industry leading RNA genomic technologies. Our submission deadline has been extended to December […]

read more